Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients
Stopped Novartis has have decided to terminate all clinical investigator-initiated research projects involving aliskiren
Conditions
- Kidney Disease
- Kidney Failure, Chronic
Interventions
- DRUG: Aliskiren
- DRUG: Placebo
Sponsor
Brigham and Women's Hospital
Collaborators